Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Author reply.

Palamuthusingam D, Johnson DW, Hawley CM, Pascoe EM, Fahim M.

Intern Med J. 2019 Oct;49(10):1340-1341. doi: 10.1111/imj.14586. No abstract available.

PMID:
31602771
2.

Infection-Related Mortality in Recipients of a Kidney Transplant in Australia and New Zealand.

Chan S, Pascoe EM, Clayton PA, McDonald SP, Lim WH, Sypek MP, Palmer SC, Isbel NM, Francis RS, Campbell SB, Hawley CM, Johnson DW.

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1484-1492. doi: 10.2215/CJN.03200319. Epub 2019 Aug 27.

PMID:
31455690
3.

Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.

Yang WL, Bose B, Zhang L, Mcstea M, Cho Y, Fahim M, Hawley CM, Pascoe EM, Johnson DW.

PLoS One. 2019 Aug 23;14(8):e0221531. doi: 10.1371/journal.pone.0221531. eCollection 2019.

4.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
5.

Identifying geospatial "hot spots" of glomerular diseases: opportunities and challenges.

Hawley CM, Pascoe EM.

Kidney Int. 2019 Aug;96(2):277-280. doi: 10.1016/j.kint.2019.04.036.

PMID:
31331466
6.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

7.

Osteosarcoma in a Child Below 2 Years of Age: Case Report and Review of the Literature.

Pascoe EM, Free M, Mackie PS, Donnan L, O'Sullivan M, Sullivan MJ, Heath JA.

J Pediatr Hematol Oncol. 2019 Jul;41(5):410-412. doi: 10.1097/MPH.0000000000001315.

PMID:
30303869
8.

Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the balANZ Trial.

Nataatmadja MS, Johnson DW, Pascoe EM, Darssan D, Hawley CM, Cho Y; balANZ Trial Investigators.

Perit Dial Int. 2018 Sep-Oct;38(5):349-355. doi: 10.3747/pdi.2017.00223. Epub 2018 Aug 7.

PMID:
30087174
9.

Direct Anterior Approach Total Hip Arthroplasty: An Adjunct to an Enhanced Recovery Pathway: Outcomes and Learning Curve Effects in Surgeons Transitioning From Other Surgical Approaches.

Free MD, Owen DH, Agius PA, Pascoe EM, Harvie P.

J Arthroplasty. 2018 Nov;33(11):3490-3495. doi: 10.1016/j.arth.2018.06.033. Epub 2018 Jul 4.

PMID:
30055885
10.

The Relationship Between Body Mass Index and Organism-Specific Peritonitis.

Jegatheesan D, Johnson DW, Cho Y, Pascoe EM, Darssan D, Htay H, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Nadeau-Fredette AC.

Perit Dial Int. 2018 May-Jun;38(3):206-214. doi: 10.3747/pdi.2017.00188.

PMID:
29848600
11.

Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.

Ahn T, Ellis RJ, White VM, Bolton DM, Coory MD, Davis ID, Francis RS, Giles GG, Gobe GC, Hawley CM, Johnson DW, Marco DJT, McStea M, Neale RE, Pascoe EM, Wood ST, Jordan SJ; IMPROVE investigators.

J Surg Oncol. 2018 Jun;117(7):1597-1610. doi: 10.1002/jso.25037. Epub 2018 May 22.

PMID:
29790163
12.

Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.

Krishnasamy R, Hawley CM, Jardine MJ, Roberts MA, Cho YJ, Wong MG, Heath A, Nelson CL, Sen S, Mount PF, Pascoe EM, Darssan D, Vergara LA, Paul-Brent PA, Toussaint ND, Johnson DW, Hutchison CA.

BMC Nephrol. 2018 Apr 17;19(1):89. doi: 10.1186/s12882-018-0883-8.

13.

Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies.

Zhang Y, Darssan D, Pascoe EM, Johnson DW, Pi H, Dong J.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1742-1751. doi: 10.1093/ndt/gfy016.

PMID:
29481620
14.

Outcomes of Acinetobacter Peritonitis in Peritoneal Dialysis Patients: A Multicenter Registry Analysis.

Htay H, Cho Y, Pascoe EM, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW.

Perit Dial Int. 2018 Jul-Aug;38(4):257-265. doi: 10.3747/pdi.2017.00199. Epub 2018 Feb 7.

PMID:
29437143
15.

Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Viecelli AK, Irish AB, Polkinghorne KR, Hawley CM, Johnson DW, Mori TA, Pascoe EM, Strippoli GFM, Lok CE, Palmer SC.

Am J Kidney Dis. 2018 Jul;72(1):50-61. doi: 10.1053/j.ajkd.2017.11.017. Epub 2018 Feb 12.

PMID:
29395485
16.

Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.

See EJ, Hawley CM, Cho Y, Toussaint ND, Agar JW, Pascoe EM, Lim WH, Francis RS, Collins MG, Johnson DW.

Nephrology (Carlton). 2019 Jan;24(1):111-120. doi: 10.1111/nep.13221.

PMID:
29316017
17.

Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.

Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW.

Am J Kidney Dis. 2018 Jun;71(6):814-821. doi: 10.1053/j.ajkd.2017.10.017. Epub 2017 Dec 28.

PMID:
29289475
18.

Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.

See EJ, Johnson DW, Hawley CM, Pascoe EM, Badve SV, Boudville N, Clayton PA, Sud K, Polkinghorne KR, Borlace M, Cho Y.

Am J Kidney Dis. 2018 Aug;72(2):188-197. doi: 10.1053/j.ajkd.2017.10.019. Epub 2017 Dec 23.

PMID:
29277508
19.

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.

Viecelli AK, O'Lone E, Sautenet B, Craig JC, Tong A, Chemla E, Hooi LS, Lee T, Lok C, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Am J Kidney Dis. 2018 Mar;71(3):382-391. doi: 10.1053/j.ajkd.2017.09.018. Epub 2017 Dec 6.

PMID:
29203125
20.

Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.

Roberts MA, Darssan D, Badve SV, Carroll RP, Fahim MA, Haluska BA, Hawley CM, Isbel NM, Marshall MR, Pascoe EM, Pedagogos E, Pilmore HL, Snelling P, Stanton T, Tan KS, Tonkin AM, Vergara LA, Ierino FL.

Kidney Blood Press Res. 2017;42(6):1033-1044. doi: 10.1159/000485589. Epub 2017 Dec 4.

21.

Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the Correlates of Kidney Dysfunction-Tumour Nephrectomy Database study.

Ellis RJ, Del Vecchio SJ, Ng KL, Dimeski G, Pascoe EM, Hawley CM, Johnson DW, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC.

Transl Androl Urol. 2017 Oct;6(5):899-909. doi: 10.21037/tau.2017.08.15.

22.

The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.

Viecelli AK, Mori TA, Roy-Chaudhury P, Polkinghorne KR, Hawley CM, Johnson DW, Pascoe EM, Irish AB.

Semin Dial. 2018 May;31(3):244-257. doi: 10.1111/sdi.12658. Epub 2017 Nov 26. Review.

PMID:
29178510
23.

EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS.

See EJ, Johnson DW, Hawley CM, Pascoe EM, Darssan D, Clayton PA, Borlace M, Badve SV, Sud K, Boudville NC, Cho Y.

Perit Dial Int. 2017 Sep 28. pii: pdi.2017.00029. doi: 10.3747/pdi.2017.00029. [Epub ahead of print]

PMID:
28970365
24.

Outcomes of Corynebacterium Peritonitis: A Multicenter Registry Analysis.

Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW.

Perit Dial Int. 2017 Nov-Dec;37(6):619-626. doi: 10.3747/pdi.2017.00028. Epub 2017 Jul 11.

PMID:
28698253
25.

Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis.

Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1090-1099. doi: 10.2215/CJN.12321216. Epub 2017 Jun 21.

26.

Association Between Peritoneal Glucose Exposure and Peritonitis in Peritoneal Dialysis Patients: The balANZ Trial.

Nataatmadja M, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW; balANZ Trial Investigators.

Perit Dial Int. 2017 Jul-Aug;37(4):407-413. doi: 10.3747/pdi.2016.00263. Epub 2017 Apr 13. Erratum in: Perit Dial Int. 2017 Jul-Aug;37(4):486.

PMID:
28408714
27.

The SIESTA Trial: A Randomized Study Investigating the Efficacy, Safety, and Tolerability of Acupressure versus Sham Therapy for Improving Sleep Quality in Patients with End-Stage Kidney Disease on Hemodialysis.

Shen K, Cho Y, Pascoe EM, Hawley CM, Oliver V, Hughes KM, Baer R, Frazier J, Jarvis E, Tan KS, Liu X, Gobe G, Johnson DW.

Evid Based Complement Alternat Med. 2017;2017:7570352. doi: 10.1155/2017/7570352. Epub 2017 Feb 21.

28.

Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients.

Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M, Badve SV, Sud K, Hawley CM, Johnson DW.

Perit Dial Int. 2017 Jul-Aug;37(4):397-406. doi: 10.3747/pdi.2016.00209. Epub 2017 Feb 9.

PMID:
28183859
29.

Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029.

30.

Teaching peritoneal dialysis in Australia: An opportunity for improvement.

Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Howard K, Johnson DW, Jose M, Lee A, Maley MA, Moodie JA, Pascoe EM, Steiner GZ, Tomlins M, Voss D, Chow J.

Nephrology (Carlton). 2018 Mar;23(3):259-263. doi: 10.1111/nep.12992.

PMID:
28042933
31.

Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The balANZ Trial.

Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Johnson DW; balANZ trial investigators.

Perit Dial Int. 2017 May-Jun;37(3):283-289. doi: 10.3747/pdi.2016.00206. Epub 2016 Dec 1.

PMID:
27935537
32.

Representativeness of Honeypot Trial Participants to Australasian PD Patients.

HONEYPOT Trial Writing Committee, Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, Liu X, McTaggart S, Morrish AT, Playford G, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW; HONEYPOT Study Collaborative Group.

Perit Dial Int. 2017 Sep-Oct;37(5):516-522. doi: 10.3747/pdi.2016.00065. Epub 2016 Dec 1.

PMID:
27935534
33.

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.

Badve SV, Pascoe EM, Burke M, Clayton PA, Campbell SB, Hawley CM, Lim WH, McDonald SP, Wong G, Johnson DW.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1845-1855. doi: 10.2215/CJN.00190116. Epub 2016 Jul 21.

34.

Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi LS, Ong LM, Irish AB; FAVOURED study team.

Nephrology (Carlton). 2017 Oct;22(10):823-824. doi: 10.1111/nep.12823. No abstract available.

PMID:
27188542
35.

Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Olynyk JK, Ferrari P; HERO Study Collaborative Group.

Nephrology (Carlton). 2017 Jul;22(7):548-554. doi: 10.1111/nep.12815.

PMID:
27171136
36.

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.

Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Kidney Int. 2016 Jun;89(6):1337-45. doi: 10.1016/j.kint.2016.02.014. Epub 2016 Apr 8.

PMID:
27165824
37.

The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.

Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, Johnson DW.

Am J Kidney Dis. 2016 Oct;68(4):554-563. doi: 10.1053/j.ajkd.2016.03.418. Epub 2016 Apr 30. Review.

PMID:
27138469
38.

Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.

Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):223-31. doi: 10.2215/CJN.05240515. Epub 2016 Jan 15.

39.

Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry Analysis.

Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe EM, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP.

Perit Dial Int. 2016 9-10;36(5):509-18. doi: 10.3747/pdi.2015.00146. Epub 2016 Jan 13.

40.

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.

Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Isbel NM, Krum H, Pascoe EM, Perkovic V, Scaria A, Tonkin AM, Vergara LA, Hawley CM; BLOCADE Study Collaborative Group.

Am J Kidney Dis. 2016 Jun;67(6):902-11. doi: 10.1053/j.ajkd.2015.10.029. Epub 2015 Dec 22.

PMID:
26717861
41.

Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.

Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Nephrology (Carlton). 2016 May;21(5):387-96. doi: 10.1111/nep.12629.

PMID:
26393772
42.

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Badve SV, Zhang L, Coombes JS, Pascoe EM, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW; HERO Study Collaborative Group.

Can J Kidney Health Dis. 2015 Aug 18;2:33. doi: 10.1186/s40697-015-0066-5. eCollection 2015.

43.

The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW; HONEYPOT Study Collaborative Group.

Perit Dial Int. 2015 Dec;35(7):712-21. doi: 10.3747/pdi.2014.00206. Epub 2015 Jul 29.

44.

Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Viecelli AK, Pascoe EM, Polkinghorne KR, Hawley CM, Paul-Brent PA, Badve SV, Cass A, Johnson DW, Kerr PG, Mori TA, Scaria A, Hooi SL, Ong ML, Irish AB; FAVOURED Study Team.

Nephrology (Carlton). 2016 Mar;21(3):217-28. doi: 10.1111/nep.12573.

45.

Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease.

Krishnasamy R, Hawley CM, Stanton T, Pascoe EM, Campbell KL, Rossi M, Petchey W, Tan KS, Beetham KS, Coombes JS, Leano R, Haluska BA, Isbel NM.

BMC Nephrol. 2015 Jul 18;16:106. doi: 10.1186/s12882-015-0098-1.

46.

Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials.

Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW.

Nephrol Dial Transplant. 2016 Sep;31(9):1425-36. doi: 10.1093/ndt/gfv269. Epub 2015 Jul 11. Review.

PMID:
26163881
47.

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

Zhang L, Coombes J, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, On Behalf Of The Hero Study Collaborative Group.

Redox Rep. 2016 Jan;21(1):14-23. doi: 10.1179/1351000215Y.0000000022. Epub 2016 Mar 4.

PMID:
26083328
48.

An Incident Cohort Study Comparing Survival on Home Hemodialysis and Peritoneal Dialysis (Australia and New Zealand Dialysis and Transplantation Registry).

Nadeau-Fredette AC, Hawley CM, Pascoe EM, Chan CT, Clayton PA, Polkinghorne KR, Boudville N, Leblanc M, Johnson DW.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1397-407. doi: 10.2215/CJN.00840115. Epub 2015 Jun 11.

49.

Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study.

Nadeau-Fredette AC, Chan CT, Cho Y, Hawley CM, Pascoe EM, Clayton PA, Polkinghorne KR, Boudville N, Leblanc M, Johnson DW.

Nephrol Dial Transplant. 2015 Nov;30(11):1897-904. doi: 10.1093/ndt/gfv132. Epub 2015 Jun 4.

50.

Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease.

Krishnasamy R, Isbel NM, Hawley CM, Pascoe EM, Burrage M, Leano R, Haluska BA, Marwick TH, Stanton T.

PLoS One. 2015 May 15;10(5):e0127044. doi: 10.1371/journal.pone.0127044. eCollection 2015.

Supplemental Content

Loading ...
Support Center